as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
4.27%
Downside
1.26%
Upside
52 Week's Low
52 Week's High
44.59%
Downside
5.01%
Upside
Check Ani Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.1B
EPS (TTM)
7.3077
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.17%
PE Ratio (TTM)
54.02
Industry PE ratio
-0.32286624203821657
PEG Ratio
1.06
EBITDA
104.3M
Revenue (TTM)
747.4M
Profit Margin
-1.37%
Return On Equity TTM
179449000.00%
Track how Ani Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Ani Pharmaceuticals Inc in the last 5 years
Lowest (8.18x)
December 31, 2020
Industry (-0.32x)
October 18, 2025
Today (54.02x)
October 18, 2025
Highest (42.03x)
September 30, 2025
Today’s Price to Earnings Ratio: 54.02x
Compare market cap, revenue, PE, and other key metrics of Ani Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.1B | 218.19% | 54.02 | -1.37% | |
BUY | $19.6B | NA | 16.91 | 40.36% | |
BUY | $41.0B | NA | 20.44 | 13.81% | |
BUY | $13.9B | 36.66% | 41.45 | 13.88% | |
BUY | $63.8B | -11.92% | 24.8 | 27.83% |
The Ani Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ani Pharmaceuticals Inc investment value today
Current value as on today
₹1,61,899
Returns
₹61,899
(+61.9%)
Returns from Ani Pharmaceuticals Inc Stock
₹57,105 (+57.1%)
Dollar Returns*
₹4,794 (+4.79%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Ani Pharmaceuticals Inc. Average target price of $107
Get share price movements and forecasts by analysts on Ani Pharmaceuticals Inc.
What analysts predicted
11.45%UPSIDE
Target Price
$107
Current Price
$94.75
Analyzed by
11 Analysts
Target
$107.00
Ani Pharmaceuticals Inc target price $107, a slight upside of 11.45% compared to current price of $94.75. According to 11 analysts rating.
Search interest for Ani Pharmaceuticals Inc Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:22% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 16 October
Thu, 06:19 PM
-ANI Pharmaceuticals expected to report Q3 2025 results soon, with EPS projected to surge 29.9% year-over-year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, ANIP has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
Revenue is up for the last 7 quarters, 131.65M → 211.37M (in $), with an average increase of 7.3% per quarter
Best in 1 Year
In the last 1 year, ANIP has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 3 months, ANIP stock has moved up by 43.0%
Profit Down
Netprofit is down for the last 2 quarters, 15.68M → 7.73M (in $), with an average decrease of 50.7% per quarter
Organisation | Ani Pharmaceuticals Inc |
Headquarters | 210 Main Street West, Baudette, MN, United States, 56623 |
Industry | Health Technology |
CEO | Mr. Nikhil Lalwani |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Krista L. Davis | Senior VP & Chief Human Resources Officer |
Mr. Nikhil Lalwani | President, CEO & Director |
Mr. Stephen P. Carey | Senior VP of Finance & CFO |
Mr. Chad Gassert | Senior Vice President of Corporate Development & Strategy |
Mr. Muthusamy Shanmugam MS R.Ph. | Head of R&D, COO of New Jersey Operations & Director |
Ms. Elizabeth Powell J.D. | Chief Compliance Officer & Head of Legal of Rare Disease |
Dr. Mary Pao M.D., Ph.D. | Chief Medical Officer |
Ms. Meredith W. Cook J.D. | Senior VP, General Counsel & Corporate Secretary |
Mr. Christopher K. Mutz | Senior VP & Head of Rare Disease |
Mr. Ori Gutwerg | Senior Vice President of Generics |
Ani Pharmaceuticals Inc share price today is $94.75 as on at the close of the market. Ani Pharmaceuticals Inc share today touched a day high of $95.94 and a low of $90.7.
Ani Pharmaceuticals Inc share touched a 52 week high of $99.5 on and a 52 week low of $52.5 on . Ani Pharmaceuticals Inc stock price today i.e. is closed at $94.75,which is 4.77% down from its 52 week high and 80.48% up from its 52 week low.
Ani Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ani Pharmaceuticals Inc (ANIP) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Ani Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ani Pharmaceuticals Inc share’s latest price of $94.75 as on October 18, 2025 at 1:29 am IST, you will get 0.1055 shares of Ani Pharmaceuticals Inc. Learn more about
fractional shares .
Ani Pharmaceuticals Inc stock has given 218.19% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?